Hospital
LG Newcorp INC
LG Newcorp INC was paid $1.08M by Medicaid between Oct 2024 and Dec 2024, across 117 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoLG NEWCORP INC
METHUEN, MA 01844
METHUEN, MA 01844
33aNPI1265267991assigned 09/03/2024
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.08M
24GClaims18,724
24DCodes billed117
24AFirst – last monthOct 2024 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Massachusetts
Rank by total paid#47 of 66
Median peer was paid$29.11M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 18,724 | $1.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 1,116 | 1,082 | $232K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 914 | 879 | $210K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 634 | 603 | $147K |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 237 | 213 | $122K |
| 59025 | Fetal non-stress test | 6.0% | 210 | 114 | $65K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.3% | 202 | 199 | $35K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 185 | 184 | $34K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 129 | 124 | $20K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 484 | 474 | $16K |
| 93975 | 1.2% | 87 | 86 | $13K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.2% | 104 | 84 | $12K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 56 | 54 | $11K |
105 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 55 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 967 | $10K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 31 | $10K |
| ATP14 | <1% | 792 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 78 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 137 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,199 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 145 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 37 | $6K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 35 | $6K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 80 | $4K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 13 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 538 | $4K |
| 10060 | <1% | 12 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 60 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 39 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 209 | $3K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 91 | $3K |
| 84484 | <1% | 449 | $3K | |
| 84702 | <1% | 208 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 103 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $2K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 14 | $2K |
| 76801 | <1% | 61 | $2K | |
| ATP08 | <1% | 205 | $2K | |
| 81025 | <1% | 255 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 229 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $2K |
| 83690 | <1% | 269 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 39 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 52 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 52 | $1K |
| 87807 | <1% | 129 | $1K | |
| 97161 | <1% | 15 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 66 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 35 | $1K |
| 81001 | <1% | 420 | $1K | |
| 84703 | <1% | 173 | $1K | |
| 87081 | <1% | 189 | $1K | |
| 74018 | <1% | 31 | $985.92 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 29 | $773.50 |
| 81003 | <1% | 401 | $706.45 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 77 | $674.45 |
| G0378 | Hospital observation service, per hour | <1% | 52 | $668.62 |
| 85379 | <1% | 77 | $664.52 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 204 | $629.73 |
| 86850 | <1% | 76 | $612.02 | |
| 80050 | General health panel | <1% | 34 | $564.80 |
| 83880 | <1% | 16 | $553.92 | |
| ATP15 | <1% | 46 | $521.64 | |
| 83605 | <1% | 38 | $346.80 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $339.30 |
| 85610 | <1% | 96 | $336.42 | |
| 90715 | <1% | 13 | $328.12 | |
| 87077 | <1% | 48 | $320.85 | |
| 87040 | <1% | 56 | $309.40 | |
| 72100 | <1% | 18 | $303.36 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 31 | $297.36 |
| 87186 | <1% | 40 | $289.94 | |
| 83735 | <1% | 48 | $277.77 | |
| 93971 | <1% | 12 | $271.16 | |
| 86900 | <1% | 102 | $250.80 | |
| 86901 | <1% | 102 | $250.80 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 31 | $239.82 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 397 | $239.33 |
| 80053 | Comprehensive metabolic panel | <1% | 904 | $217.12 |
| 82607 | <1% | 14 | $186.20 | |
| 88304 | <1% | 19 | $163.16 | |
| 85027 | <1% | 30 | $159.88 | |
| 82746 | <1% | 12 | $155.52 | |
| 73630 | <1% | 42 | $151.68 | |
| 73030 | <1% | 22 | $151.68 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 309 | $149.40 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 123 | $149.40 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 83 | $149.40 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 42 | $149.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 351 | $149.40 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $102.72 |
| 82947 | <1% | 106 | $100.63 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 347 | $99.42 |
| 85007 | <1% | 30 | $97.15 | |
| 85730 | <1% | 17 | $84.80 | |
| 73130 | <1% | 25 | $75.84 | |
| 73562 | <1% | 19 | $75.84 | |
| 71045 | Radiologic examination, chest; single view | <1% | 112 | $75.84 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 471 | $69.97 |
| 85652 | <1% | 16 | $26.18 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 414 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 74 | $0.00 |
| 73610 | 0% | 60 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 114 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 16 | $0.00 |
| 80143 | 0% | 18 | $0.00 | |
| 80061 | Lipid panel | 0% | 19 | $0.00 |
| 82565 | 0% | 13 | $0.00 | |
| 80076 | 0% | 38 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 80 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 96 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 119 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 19 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 95 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 92 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 271 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 95 | $0.00 |
| 96376 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHITLOCK, JOHN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Lawrence General Hospital | Lawrence, MA | $84.57M |
| Lawrence General Hospital | Lawrence, MA | $9.97M |
| Community Medical Associates, INC. | Lawrence, MA | $1.24M |
| General Primary Care of Lawrence | Lawrence, MA | $1.14M |
| Lawrence General Hospital | Lawrence, MA | $133K |
| Lawrence General Hospital | Lawrence, MA | $107K |
| Lawrence General Hospital | Lawrence, MA | $372.64 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.